Autophagy induced by cardamonin is associated with mTORC1 inhibition in SKOV3 cells

Daohua Shi1, Peiguang Niu1, Xiaojie Heng1

  • 1Department of Pharmacy, Fujian Provincial Maternity and Children's Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.

Abstract

Insights

Cardamonin inhibits cell viability and proliferation by inducing autophagy through mammalian target of rapamycin (mTOR) complex 1 (mTORC1) inhibition. This occurs via decreasing the regulatory associated protein of mTOR (Raptor) in SKOV3 cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pharmacology

Background:

  • Mammalian target of rapamycin (mTOR) regulates cell proliferation and autophagy.
  • Cardamonin demonstrates anti-proliferative effects by inhibiting mTOR.

Purpose of the Study:

  • To investigate the effect of cardamonin on autophagy.
  • To elucidate the mechanism of cardamonin-induced mTOR inhibition.

Main Methods:

  • Cell viability and proliferation assays (MTT, BrdU).
  • Apoptosis and autophagy detection (flow cytometry, electron microscopy, GFP-LC3).
  • Mechanism investigation using Raptor siRNA and overexpression.

Main Results:

  • Cardamonin inhibited cell viability, proliferation, and induced apoptosis.
  • Cardamonin increased autophagosomes and LC3-II levels, indicating induced autophagy.
  • Cardamonin suppressed mTORC1 signaling by reducing Raptor protein and mTOR/S6K1 phosphorylation, without affecting mTORC2/Akt.
  • Raptor modulation affected cardamonin's inhibitory effects on mTORC1 and cell viability.

Conclusions:

  • Cardamonin induces autophagy via mTORC1 inhibition.
  • The mechanism involves a decrease in Raptor protein levels in SKOV3 cells.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K